Ignite Creation Date:
2025-12-24 @ 10:07 PM
Ignite Modification Date:
2026-06-29 @ 10:50 PM
Study NCT ID:
NCT05119335
Status:
TERMINATED
Last Update Posted:
2025-11-12
First Post:
2021-10-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma
Sponsor:
NiKang Therapeutics, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | ccRCC | View |
| None | Clear Cell Renal Cell Carcinoma | View |
| None | Kidney Cancer | View |
| None | Kidney Neoplasms | View |
| None | Renal Cancer | View |
| None | Renal Neoplasms | View |
| None | Recurrent Renal Cell Carcinoma | View |
| None | Metastatic Renal Cell Carcinoma | View |
| None | Refractory Renal Cell Carcinoma | View |
| None | Advanced Renal Cell Carcinoma | View |
| None | Hypoxia | View |
| None | Renal Cell Carcinoma | View |
| None | Hypoxia Inducible Factor (HIF) | View |
| None | HIF2α Inhibitor | View |
| None | Hypoxia Inducible Factor 2 Alpha (HIF-2 Alpha) | View |
| None | Hypoxia Inducible Factor 2α (HIF-2α) | View |
| None | Clear Cell | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Hypoxia inducible factor (HIF) | View |
| None | HIF2α INHIBITOR | View |
| None | HIF1α | View |
| None | clear cell | View |
| None | Hypoxia inducible factor 2 alpha (HIF-2 alpha) | View |
| None | Hypoxia inducible factor 2α (HIF-2α) | View |
| None | Renal Cell Carcinoma (RCC) | View |
| None | Kidney Cancer | View |